Copyright
©2010 Baishideng.
World J Gastroenterol. Aug 14, 2010; 16(30): 3793-3803
Published online Aug 14, 2010. doi: 10.3748/wjg.v16.i30.3793
Published online Aug 14, 2010. doi: 10.3748/wjg.v16.i30.3793
Studies | Histology | Treatment | n | MS (mo) | 5-yr OS (%) | P | RT dose (Gy) |
Kunath et al[44], 1984 | SCC | ART | 23 | 9 | NS | 50-55 | |
Surgery | 21 | 6 | |||||
Ténière et al[45], 1991 | SCC | ART | 102 | 18 | 19 | NS | 45-55 |
Surgery | 119 | 18 | 19 | ||||
Fok et al[36], 1993 | SCC | ART | 42 | 11 | 10 | NS | 43-53 |
Surgery | 39 | 22 | 16 | ||||
Zieren et al[46], 1995 | SCC | ART | 33 | 231 | NS | 56 | |
Surgery | 35 | 221 | |||||
Xiao et al[47], 2003 | AC/SCC | ART | 220 | 41 | NS | 50-60 | |
Surgery | 275 | 32 |
- Citation: Campbell NP, Villaflor VM. Neoadjuvant treatment of esophageal cancer. World J Gastroenterol 2010; 16(30): 3793-3803
- URL: https://www.wjgnet.com/1007-9327/full/v16/i30/3793.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i30.3793